Ohio Public Employees Retirement System (OPERS)
TCRX icon

Ohio Public Employees Retirement System (OPERS)’s TScan Therapeutics TCRX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.9K Buy
36,600
+8,900
+32% +$9.48K ﹤0.01% 2070
2026
Q1 		$28K Buy
+27,700
New +$29.6K ﹤0.01% 2112

Other funds holding TCRX

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s TCRX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its TScan Therapeutics (TCRX) stake by 32% in Q2 2026, buying an estimated $9.48K and bringing the position to 36,600 shares worth $35.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.

Ohio Public Employees Retirement System (OPERS) first reported a position in TCRX in Q1 2026 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold TCRX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 36,600 shares of TScan Therapeutics worth $35.9K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 8,900 TScan Therapeutics shares in Q2 2026, an estimated $9.48K.
  • TScan Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #2070 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in TScan Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held TScan Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.